Clinical Trial Update: Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps [Phase 4]

View source ↗

Summary

Phase 4 trial update on Gammanorm quality-of-life in immunodeficient patients using rapid push or pumps has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immunodeficiency

Drugs mentioned

• Gammanorm

Snippet

Sponsor: Octapharma | Conditions: Primary Immunodeficiency (PID) | Phase 4 | Status: COMPLETED